Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spero Therapeutics (SPRO) Preferred Dividend Payments (2016 - 2017)

Historic Preferred Dividend Payments for Spero Therapeutics (SPRO) over the last 2 years, with Q4 2017 value amounting to $833000.0.

  • Spero Therapeutics' Preferred Dividend Payments fell 925.93% to $833000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $6.1 million, marking a year-over-year change of. This contributed to the annual value of $6.1 million for FY2017, which is 7861.09% up from last year.
  • Latest data reveals that Spero Therapeutics reported Preferred Dividend Payments of $833000.0 as of Q4 2017, which was down 925.93% from $2.1 million recorded in Q3 2017.
  • In the past 5 years, Spero Therapeutics' Preferred Dividend Payments registered a high of $2.1 million during Q3 2017, and its lowest value of $833000.0 during Q4 2017.